Antengene unveils three pipeline programs at AACR 2026 as AnTenGager platform expands beyond UCB deal
Can Kailera become the next major GLP-1 challenger after pricing one of biotech’s biggest IPOs in years?
Read More General business news How AtlasClear’s Wilson-Davis turned moderate revenue growth into a 295% net income explosion AtlasClear’s Wilson-Davis subsidiary delivered a 295 % profit surge on modest revenue growth—find out how this clearing-business breakthrough is reshaping investor confidence. bySoujanya RaviOctober 28, 2025